Are you Dr. Hess?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Summary
- Dr. Brian Hess, MD is an oncologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina, Missouri, and Illinois. He is affiliated with MUSC Health University Medical Center.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2013 - 2016
- Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
- University of Missouri-Columbia School of MedicineClass of 2010
Certifications & Licensure
- SC State Medical License 2016 - 2025
- MO State Medical License 2014 - 2017
- IL State Medical License 2010 - 2014
Publications & Presentations
PubMed
- : A condensed step-up dosing schedule of teclistamab for relapsed/refractory multiple myeloma.Kevin C Graf, James A Davis, Alyssa Cendagorta, Katelynn Granger, Kelly J Gaffney
Ejhaem. 2024-08-01 - 6 citationsEpcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.Kim M Linton, Umberto Vitolo, Wojciech Jurczak, Pieternella J Lugtenburg, Emmanuel Gyan
The Lancet. Haematology. 2024-08-01 - 3 citationsSubsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Pamela Allen
Blood Advances. 2024-05-28
Press Mentions
- Medical Student Carries Her Lymphoma Experience with HerMarch 15th, 2023
- Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab Protects Blood Cancer Patients Against COVIDDecember 16th, 2022
- Oncologist Leaves a Lasting Legacy at MUSC Hollings Cancer CenterJune 23rd, 2021